ALLUCENT
LIVE

Serial Number

97978222

Owner

Clinical Services Corporate Operations, Inc.

Attorney

Becky Troutman

First Use Date

May 1, 2022

Filing Date

Apr 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ALLUCENT Trademark

Serial Number: 97978222 • Registration: 7464174

ALLUCENT is a trademark filed by Clinical Services Corporate Operations, Inc. on April 20, 2022. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Clinical Services Corporate Operations, Inc. (12 trademarks)

Waltham, MA 02452

Entity Type: 03

Trademark Details

Filing Date

April 20, 2022

Registration Date

July 30, 2024

First Use Anywhere

May 1, 2022

First Use in Commerce

May 1, 2022

Published for Opposition

September 5, 2023

Goods & Services

Cloud computing featuring software that allows users to collect, review, analyze and report on clinical research; technical support services, namely, installation and remote administration of software, and troubleshooting of software problems and hosted software applications, all for use in connection with medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; cloud computing featuring software for providing telehealth, telemedicine, remote care and virtual health care services to patients; cloud computing featuring software that allows users to collect, track, retrieve, validate, summarize, statistically analyze and present data used in the areas of medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; Cloud computing featuring software to aggregate, integrate, transfer and manage data generated from home health and remote monitoring devices and applications and health-related smart-phone applications; Cloud computing featuring software that provides integrated workflows, analytics, visualizations, and reporting features to deliver, process, analyze, elevate, and display patient-generated health data; Cloud computing featuring software that integrates remotely collected health data into databases, systems, platforms, applications, and software that inform clinical research, remote monitoring, and care management; technical consulting services, namely, evaluating the safety of pharmaceutical, medical, cosmetic and consumer devices and products in clinical development or in commercial production; Consulting services for others in the fields of design, planning, implementation and project management of clinical trials; Scientific analysis of statistical and qualitative data relating to clinical trials for pharmaceuticals, biotechnology, medical devices and diagnostics for scientific research and for the development of pharmaceutical, biotechnology, medical device and diagnostic products and methods of use of such devices and products

Development of regulatory compliance strategies in the field of medical research, namely, regulatory compliance consulting in the field of drug, biologic, cosmetic and medical device development

Training and development in the field of conducting clinical trials, namely, conducting tutorials, seminars and workshops in the field of clinical trials; training in the field of computer software support, namely, conducting tutorials, seminars and workshops in the field of software support

Data management, namely, abstraction services in the nature of extracting and summarizing information from clinical trial records and collection of medical data from clinical tests and records for business purposes; Market research and business marketing consulting services in the pharmaceutical, biotechnology, medical device, and diagnostics industries; Data management, namely, the management for others of databases of patient health data

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 30, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 25, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 25, 2024 CNPR
ASSIGNED TO EXAMINER
Jun 25, 2024 DOCK
STATEMENT OF USE PROCESSING COMPLETE
May 21, 2024 SUPC
DIVISIONAL PROCESSING COMPLETE
May 21, 2024 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 2, 2024 AITU
USE AMENDMENT FILED
Apr 11, 2024 IUAF
DIVISIONAL REQUEST RECEIVED
Apr 11, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Apr 11, 2024 ERTD
TEAS STATEMENT OF USE RECEIVED
Apr 11, 2024 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 11, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 11, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 11, 2024 COAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 4, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 4, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 4, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 4, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 27, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 26, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 26, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 26, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 31, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 5, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 29, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 29, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 29, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 29, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 13, 2023 ZZZX
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Jul 13, 2023 PBSR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 3, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 21, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 16, 2023 GNFN
FINAL REFUSAL E-MAILED
May 16, 2023 GNFR
FINAL REFUSAL WRITTEN
May 16, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 6, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 6, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jan 6, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jan 6, 2023 CNRT
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Jan 4, 2023 LOPR
ASSIGNED TO EXAMINER
Dec 28, 2022 DOCK
LETTER OF PROTEST EVIDENCE FORWARDED
Nov 21, 2022 LOPT
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 27, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2022 NWOS
NEW APPLICATION ENTERED
Apr 23, 2022 NWAP